Zach Scheiner
Direttore/Membro del Consiglio presso NKARTA, INC.
Patrimonio netto: - $ in data 31/05/2024
Provenienza dei contatti di primo grado di Zach Scheiner
| Entità | Tipo di entità | Settore Industriale | |
|---|---|---|---|
Yale University
454
| College/University | Other Consumer Services | 454 |
University of Washington
 University of Washington Other Consumer ServicesConsumer Services University of Washington functions as a College/University. The company is headquartered in Seattle, WA.
284
| College/University | Other Consumer Services | 284 |
RA Capital Management LP (Private Equity)
 RA Capital Management LP (Private Equity) Investment ManagersFinance RA Capital Management LP (Private Equity) (RA Capital) is a private equity & venture capital subsidiary of RA Capital Management LP founded by Peter Kolchinsky in 2004. The firm is headquartered in Boston, MA.
29
| Operating Division | Investment Managers | 29 |
RA Capital Management LP
 RA Capital Management LP Investment ManagersFinance RA Capital Management LP (RA Capital) is an independent, SEC-registered investment advisor and hedge fund manager headquartered in Boston, Massachusetts. The firm was founded by Peter Kolchinsky in 2004. RA Capital provides discretionary investment advisory services to Healthcare Funds and the Nexus Funds which are open only to certain financially sophisticated and high net-worth individuals and entities.
18
| Private Company | Investment Managers | 18 |
16
| Public Company | Biotechnology | 16 |
Exo Imaging, Inc.
 Exo Imaging, Inc. Packaged SoftwareTechnology Services eXo Imaging, Inc. engages in the provision of ultrasound platform and AI for imaging and therapeutic applications. The company was founded by Sandeep Akkaraju, Janusz Bryzek, Yusuf Haque, and John Kokulis and is headquartered in Redwood City, CA.
9
| Holding Company | Packaged Software | 9 |
California Institute for Regenerative Medicine
8
| Government | General Government | 8 |
Sydnexis, Inc.
 Sydnexis, Inc. Pharmaceuticals: MajorHealth Technology Sydnexis, Inc. engages in the production of ophthalmic pharmaceutical products. The company was founded by Gregory Isaac Ostrow in 2014 and is headquartered in San Diego, CA.
7
| Holding Company | Pharmaceuticals: Major | 7 |
LENZ Therapeutics, Inc.
 LENZ Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology LENZ Therapeutics, Inc. manufactures pharmaceuticals. The firm sells eye care products. The company was founded by James W. McCollum, Lee Nordan and Gerald Horn and is headquartered in Coronado, CA.
6
| Subsidiary | Pharmaceuticals: Major | 6 |
Adagio Medical, Inc.
 Adagio Medical, Inc. Medical SpecialtiesHealth Technology Adagio Medical, Inc. provides medical devices. Its products include catheters, esophageal balloon and console. The firm offers transmural lesions to treat cardiac arrhythmias, including paroxysmal and persistent atrial fibrillation, atrial flutter, and ventricular tachycardia. The company was founded by James Cox and Olav Bergheim in 2011 and is headquartered in Laguna Hills, CA.
4
| Holding Company | Medical Specialties | 4 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Zach Scheiner tramite i suoi contatti personali
| Società | Settore | Persone collegate | Posizione principale |
|---|---|---|---|
| CHEMOCENTRYX, INC. | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal | |
ViaCyte, Inc.
 ViaCyte, Inc. Pharmaceuticals: MajorHealth Technology ViaCyte, Inc. develops a stem cell-derived islet replacement therapy for the treatment of diabetes. Its development portfolio includes VC-01 product candidate, a cell replacement therapy for the treatment of type 1 diabetes. The company was founded in 1999 and is headquartered in San Diego, CA. | Pharmaceuticals: Major | Director/Board Member Director of Finance/CFO | |
| ACHILLION PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chief Executive Officer Chief Tech/Sci/R&D Officer | |
| ONCOMED PHARMACEUTICALS INC | Pharmaceuticals: Major | Chief Executive Officer General Counsel | |
| VISTERRA INC | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Ivantis, Inc.
 Ivantis, Inc. Medical SpecialtiesHealth Technology Ivantis, Inc. develops technology to treat ophthalmic diseases. The firm develops solutions for glaucoma and offers an intracanalicular scaffold or implantable device that relieves high intraocular pressures in patients. It provides its solutions for use in clinical trials to ophthalmology specialists. Ivantis was founded in 2007 and is headquartered in Irvine, CA. | Medical Specialties | Director/Board Member Director/Board Member | |
| RA PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Chief Tech/Sci/R&D Officer | |
| WAVE LIFE SCIENCES LTD. | Biotechnology | Director/Board Member Director/Board Member | |
McKinsey & Co., Inc.
 McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services McKinsey & Co., Inc. provides management consulting services. It specializes in design, marketing and sales, analytics, operations, transformation and restructuring, risk, strategy and corporate finance, and sustainability and resource productivity. The company was founded by James O. McKinsey in 1926 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
Duke University
 Duke University Other Consumer ServicesConsumer Services Duke University is an academic university that offers undergraduate, graduate and professional programs. It also has publications and research services. The university was founded in 1838 and is headquartered in Durham, NC. | College/University | Masters Business Admin Undergraduate Degree Undergraduate Degree | |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Corporate Officer/Principal Doctorate Degree Doctorate Degree Doctorate Degree Undergraduate Degree Doctorate Degree Doctorate Degree Undergraduate Degree | |
| Stanford University | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
| University of Pennsylvania | College/University | Undergraduate Degree Doctorate Degree | |
| College of the Holy Cross (Massachusetts) | College/University | Undergraduate Degree Undergraduate Degree | |
Atlas Venture Advisors, Inc.
 Atlas Venture Advisors, Inc. Investment ManagersFinance Atlas Venture Advisors Inc (Atlas Venture Advisors) is a venture capital firm founded in 1980 by Christopher Julian Spray. The firm is headquartered in Cambridge, Massachusetts. | Investment Managers | Consultant / Advisor Private Equity Investor | |
| Massachusetts Institute of Technology | College/University | Doctorate Degree Undergraduate Degree Graduate Degree Undergraduate Degree | |
Cornell University
 Cornell University Other Consumer ServicesConsumer Services Cornell University is an educational institution that offers undergraduate and post graduate programs. It was founded in 1865 and is based in Ithaca, NY. | College/University | Undergraduate Degree Undergraduate Degree | |
| University of California, Berkeley | College/University | Corporate Officer/Principal Doctorate Degree Graduate Degree Doctorate Degree | |
| University of Georgia | College/University | Undergraduate Degree Undergraduate Degree | |
| The University of North Carolina at Chapel Hill | College/University | Graduate Degree Undergraduate Degree | |
Tel-Aviv University
 Tel-Aviv University Other Consumer ServicesConsumer Services Tel-Aviv University operates as a university in Israel. Its faculties include arts, engineering, science, humanities, law, life science, management, medicine, and social science. The company was founded in 1956 and is headquartered in Ramat Aviv, Israel. | College/University | Doctorate Degree Masters Business Admin | |
Yale New Haven Health Services Corp.
 Yale New Haven Health Services Corp. Miscellaneous Commercial ServicesCommercial Services Yale-New Haven Health Services Corp. operates as a non-profit organization that provides healthcare services. It offers geriatrics, oncology, neurology and neurosurgery, orthopedics, primary care, transplantation, clinical programs and services, health education, and research and clinical trials. The company was founded in 1995 and is headquartered in New Haven, CT. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
Yale-New Haven Hospital, Inc.
 Yale-New Haven Hospital, Inc. Hospital/Nursing ManagementHealth Services Yale-New Haven Hospital, Inc. provides health care services and medical courses. The firm’s clinical programs and services include advanced vascular imaging services, allergy and immunology, ambulatory services, bariatric surgery program, cardiac rehabilitation, dental services, dermatology services, diabetes and endocrinology, ear, nose & throat (otolaryngology), electrophysiology and cardiac arrhythmia service and interventional cardiology. The company was founded in 1826 and is headquartered in New Haven, CT. | Hospital/Nursing Management | Director/Board Member Director/Board Member Corporate Officer/Principal | |
Equinox Ophthalmic, Inc.
 Equinox Ophthalmic, Inc. Miscellaneous Commercial ServicesCommercial Services Equinox Ophthalmic, Inc. operates as a biotechnology company. It specializes in cataract, corneal and glaucoma surgery. The company was founded by John Berdahl and is headquartered in Sioux Falls, SD. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
KalVista Pharmaceuticals Ltd.
 KalVista Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology KalVista Pharmaceuticals Ltd. develops novel plasma kallikrein inhibitors. It also engages in the development of serine protease inhibitors and novel plasma kallikrein inhibitors represent a, approach to the treatment of DME, a leading cause of adult visual loss, plasma kallikrein inhibitors target a distinct molecular pathway and as such have the potential to offer those patients an effective treatment option. The firm has a clinical and advanced pre-clinical product pipeline targeting both intravitreal injection and oral administration, and its plasma kallikrein inhibitors can be applied to additional indications in ophthalmology. The company was founded by Lloyd Paul Aiello, Andrew Crockett, Robert Haigh and Edward P. Feener in 2011 and is headquartered in Porton Down, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| SPERO THERAPEUTICS, INC. | Biotechnology | Founder Director/Board Member Director/Board Member | |
| SYNTHORX, INC. | Biotechnology | Director/Board Member Director/Board Member | |
Tasso, Inc.
 Tasso, Inc. Medical SpecialtiesHealth Technology Tasso, Inc. develops devices for collecting blood samples. It offers HemoLink, a device which is used to self-collect blood for clinical testing. The company was founded by Benjamin J. Moga, Erwin Berthier and Ben Casavant and is headquartered in Seattle, WA. | Medical Specialties | Director/Board Member Director/Board Member | |
| VOR BIOPHARMA INC. | Biotechnology | Director/Board Member Chief Tech/Sci/R&D Officer | |
Jnana Therapeutics, Inc.
 Jnana Therapeutics, Inc. BiotechnologyHealth Technology Jnana Therapeutics, Inc. provides drug development services. The firm focuses on immunometabolism changing the metabolic pathways in immune cells to affect function; lysosomal function and mucosal defense. The company was founded by Stuart L. Schreiber, Ramnik Xavier, Joanne Kotz and Joel C. Barrish and is headquartered in Boston, MA. | Biotechnology | Founder Director/Board Member | |
Clear Creek Bio, Inc.
 Clear Creek Bio, Inc. Pharmaceuticals: MajorHealth Technology Clear Creek Bio, Inc. engages in the development of therapies that target nucleotide synthesis pathways. The firm focuses on the differentiation blockade in cancer and suppress replication of RNA-based viruses. It uses pharmacodynamic markers to ensure that each patient gets the right drug at the correct dose. The company was founded by David T. Scadden, David B. Sykes, Burt A. Adelman, and Vikram Sheel Kumar in 2017 and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
California Life Sciences Association
 California Life Sciences Association Miscellaneous Commercial ServicesCommercial Services California Life Sciences Association (CLSA) is the largest and most influential life sciences advocacy and business leadership organization in California. The non-profit company is based in South San Francisco, CA, and has offices in other locations as well. The company works closely with industry, government, academia, and others to shape public policy, improve access to innovative technologies, and grow California's life sciences economy. CLSA serves biotechnology, pharmaceutical, medical device, and diagnostics companies, research universities and institutes, investors, and service providers throughout the state. Mike Guerra has been the CEO of the company since 2019. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
Nayan Therapeutics, Inc.
 Nayan Therapeutics, Inc. BiotechnologyHealth Technology Nayan Therapeutics, Inc. operates as a biotechnology company. It focuses on small molecule development for oscular disorders involving rod degeneration. The company is headquartered in Medfield, MA. | Biotechnology | Chief Executive Officer Director/Board Member | |
| ELIEM THERAPEUTICS, INC. | Biotechnology | Director/Board Member Director/Board Member Chief Executive Officer | |
TherOptix, Inc.
 TherOptix, Inc. Electronic ComponentsElectronic Technology TherOptix, Inc. develops and manufactures drug-eluting contact lens. The company is headquartered in San Francisco, CA. | Electronic Components | Director/Board Member Director/Board Member | |
Santi Therapeutics, Inc.
 Santi Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Santi Therapeutics, Inc. provides pharmaceutical services. The company is headquartered in Boston, MA. | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member | |
Sionna Therapeutics, Inc.
 Sionna Therapeutics, Inc. Medical/Nursing ServicesHealth Services Sionna Therapeutics, Inc. is a clinical-stage life sciences company located in Natick, MA. The company is dedicated to developing highly effective and differentiated treatments for cystic fibrosis (CF) by normalizing the function of CFTR, the key protein associated with disease progression in CF. Sionna is advancing a pipeline of small molecules engineered to correct the protein defects caused by ?F508, the most common mutation that affects the CFTR protein. The company has a first-in-class portfolio of programs directly targeting correction of ?F508-CFTR, the key and unique mechanism to enable full restoration of ?F508-CFTR function, and complementary programs targeting ICL4 and more. The CEO of the company is Michael Cloonan. | Medical/Nursing Services | Director/Board Member Director/Board Member Chief Executive Officer | |
| PEPGEN INC. | Biotechnology | Director/Board Member Chairman | |
Avilar Therapeutics, Inc.
 Avilar Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Avilar Therapeutics is an American biopharmaceutical company that specializes in the discovery and development of extracellular protein degraders. The company is based in an undisclosed location. The company has developed a proprietary discovery platform that includes novel, high-affinity, small molecule asgpr ligands and advanced modeling of the biophysics, pharmacokinetics, and pharmacodynamics of atac mediated endocytosis and degradation. Avilar is developing atacs, a new class of protein degraders that shuttle disease-causing proteins from circulation to the endolysosome where the unwanted proteins are degraded. The company is leveraging their atac platform to create a broad and diverse pipeline of first-in-class extracellular protein degraders. The company was founded by Nathaniel Brooks Horwitz and Jamie Kasuboski. The CEO is Daniel S. Grau. | Miscellaneous Commercial Services | Chairman Chief Executive Officer Founder Director/Board Member | |
| RESEARCH ALLIANCE CORP. II | Financial Conglomerates | Chief Executive Officer Founder Director of Finance/CFO | |
Aliada Therapeutics, Inc.
 Aliada Therapeutics, Inc. BiotechnologyHealth Technology Aliada Therapeutics, Inc. is a neuroscience-focused company that aims to overcome the delivery hurdle in large molecule drug development. The company is based in Boston, MA. The company is advancing a generation of CNS therapeutics using its novel BBB crossing platform technology, which can efficiently transport a diverse array of therapeutic cargoes into the brain, resulting in enhanced downstream effectiveness. Aliada Therapeutics was founded by Sanjaya Singh, and the CEO is Adam Rosenberg. | Biotechnology | Chief Executive Officer Director/Board Member Director/Board Member | |
Stylus Medicine, Inc.
 Stylus Medicine, Inc. Medical SpecialtiesHealth Technology Stylus Medicine, Inc. is a company focused on developing innovative solutions to combat diseases using cutting-edge genome engineering and chromatin regulation technologies. Stylus Medicine is based in Boston, MA. The company is backed by RA Ventures and Khosla Ventures. | Medical Specialties | Director/Board Member President | |
| Boston University School of Medicine | College/University | Corporate Officer/Principal Graduate Degree |
Statistiche
Distribuzione geografica
| Stati Uniti | 46 |
| Singapore | 2 |
| Israele | 2 |
| Regno Unito | 2 |
Settori
| Health Technology | 26 |
| Consumer Services | 12 |
| Commercial Services | 6 |
| Finance | 5 |
| Health Services | 3 |
Posizioni
| Director/Board Member | 497 |
| Corporate Officer/Principal | 164 |
| Independent Dir/Board Member | 105 |
| Undergraduate Degree | 81 |
| Chief Executive Officer | 72 |
Contatti più connessi
| Insiders | |
|---|---|
| Richard Lindstrom | 50 |
| Joshua Resnick | 36 |
| Ali Behbahani | 35 |
| Peter Kolchinsky | 32 |
| Edward Penhoet | 29 |
| Olav Bergheim | 28 |
| Bing Yuan | 26 |
| Fouad Azzam | 25 |
| Risa Stack | 25 |
| Paul Hastings | 25 |
| Kenneth Widder | 24 |
| Suzanne Foster | 23 |
| Andrew Levin | 21 |
| Richard Levin | 20 |
| Gregory Grunberg | 20 |
- Borsa valori
- Insiders
- Zach Scheiner
- Connessioni Società
